Niche U.S. Equities Face Strategic Shifts From Aviation Buyouts to Biotech Pipeline AdvancesGlobal Report·19 hours agoFLY-3.64%ARCT+7.67%
Arcturus Therapeutics to Present ARCT-810 Data on OTC Deficiency at 2026 SymposiumTradingView·21 hours agoARCT+7.67%
Mixed Signals Emerge Across Specialized Assets and Energy MarketsGlobal Report·22 hours agoLEGN+1.72%AVEX-3.06%
12 Health Care Stocks Moving In Friday's Intraday Sessionbenzinga_article·Aug 21 at 12:06 PMPFSA+9.17%ZSTK+27.87%
Elon Musk Says mRNA Has 'Tremendous Promise,' Turning Disease Into a 'Software Problem,' as Moderna Stock Rockets 177% on Cancer Vaccine Breakthroughbenzinga_article·Aug 19 at 10:18 PMMRNA+14.36%MRK+3.84%
12 Health Care Stocks Moving In Wednesday's Pre-Market Sessionbenzinga_article·Aug 19 at 07:07 AMAIXC-0.52%TNON-10.94%
Macro Repricing: Geopolitics Lift Offshore Drillers as Pipeline Data Splits Biotech ValuationsGlobal Report·Aug 19 at 04:43 AMGFR.RT*0.00%ARCT+7.67%
The Micro-Dramas of the 2026 Market: From Regional Banks to Energy ComebacksGlobal Report·Aug 19 at 04:43 AMYMM+3.91%SMFG+0.72%
Specialized Industrials and Alternative Assets Deliver Robust 2026 Earnings as Markets HedgeGlobal Report·Aug 12 at 05:13 AMTDG-0.54%KYCCF+4.95%
Arcturus Therapeutics Eyes Phase III CF Call, OTC Data as Vaccine Funds PipelineMarket Beat·Aug 11 at 08:04 PMARCT+7.67%TMO-0.09%
Arcturus Q2 FY26 net loss widens to $23.8 million; revenue drops 89.5% to $3 millionPUBT·Aug 6 at 03:07 PMARCT+7.67%
